Skip to main content
Lisa Roth, MD, Pediatric Hematology & Oncology, New York, NY

LisaGiulinoRothMD

Pediatric Hematology & Oncology New York, NY

Pediatric Hematologic Oncology

Assistant Professor of Pediatrics

Overview of Dr. Roth

Dr. Lisa Roth is a pediatric hematologist/oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from New York University Grossman School of Medicine and has been in practice 12 years. She is one of 135 doctors at New York-Presbyterian Hospital and one of 37 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Pediatric Hematology & Oncology. She has more than 30 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2008 - 2011
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2005 - 2008
  • New York University School of Medicine
    New York University School of MedicineClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Combined EZH2 and BCL2 Inhibitors As Precision Therapy for Genetically Defined DLBCL Subtypes
    Lisa Giulino Roth, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Lymphomas in the Young and the Old: How Do They Differ?
    Lymphomas in the Young and the Old: How Do They Differ?September 10th, 2024
  • Awareness Increases of Unique Needs of AYA Lymphoma Patients
    Awareness Increases of Unique Needs of AYA Lymphoma PatientsJune 21st, 2017